100 mg Blister
Topiramate is a medication available in 100 mg doses. Lot numbers and expiration dates are provided.*
Topiramate Tablet, Film Coated
Product Images NDC 68084-344
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68084-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
100 mg Carton
Topiramate is a prescription tablet medication that comes in a bottle of 100 tablets (10 x 10). Each tablet contains 100mg of Topiramate USP. The usual dosage is listed in the package insert for prescribing information. It should be stored between 20°C and 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (58°F and 86°F), and protected from moisture. This medication should be kept out of reach of children and should not be used if the blister is open or broken. The drugs come from package KD 58362140, 008 Pharmaceuticals, and are distributed by American Health Packaging of Columbus, Ohio. Dispensing of the medication must be accompanied by the Medication Guide.*
200 mg Blister
200 mg Carton
This is a description of a drug with the NDC code 68084-345-21 called Topiramate, which comes in a bottle of 30 tablets of 200mg each, to be used with a prescription. It needs to be stored between 20 and 25°C, and protected from moisture. The packaging and distribution is handled by Armarcan Seati Packaging in Columbus, Ohio. No further information is available from the text provided.*
25 mg Blister
25 mg Carton
This is a description of a medication labeled as NDC 68084-342-01 Topiramate Tablets, USP, and includes 100 tablets. The tablets are dispensed with an accompanying medication for each patient. The drug product information is from N # 65382.138, from Iss Pranmacutcals USA. The manufacturer and distributor of this drug are American Health Packaging in Columbus, Ghio. The package insert contains full prescribing information and the usual dosage. The drug should be stored at controlled room temperature and protected from moisture. It is important to keep this and all drugs out of reach of children. The text also includes a warning to not use damaged or broken tablets.*
50 mg Blister
Topiramate is a medication available in tablet form with varying strengths. The dosage options include 50mg, 75mg, and 100mg. However, due to the poor quality, it is difficult to determine the complete description.*
50 mg Carton
This is a medication called Topiramate available in tablet form. It comes in a pack of 100 tablets and the usual dosage has to be prescribed after consulting the package insert. The tablets should be stored at a temperature between 20-25°C (68-77°F) with excursions permitted between 10-30°C (55-71°F). It is important to keep the medication out of reach of children and not use it if the blister packaging is broken. The manufacturer of the drug product contained in this package is Pharmaceutical USA Inc. This medication should only be dispensed with accompanying medication and to the named patient, as instructed by the pharmacist.*
Ahp34201
Ahp34301
Ahp34401
Ahp34521
Figure 1
This is a graph showing the Kaplan-Meler Estimates of Cumulative Ratos for Time to First Seizure in Study 1 for two groups of individuals who received different doses of Topiramate. The cumulative rate for the group receiving 50 mg/day is plotted with dashes and the group receiving 400 mg/day is plotted with a solid line. The x-axis represents time in days and the y-axis represents the percentage of individuals who have not experienced a seizure. The graph shows that the group receiving the higher dose of Topiramate has a lower cumulative rate of first seizures over time.*
Figure 2
The text shows the monthly migraine period rate for a study involving different dosages of Topiramate and Placebo. The data is presented in a table format indicating the sample size for each group. There are also significance levels indicated at the bottom of the table.*
Structure
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
